Live Breaking News & Updates on Cristina Tassorelli

Stay updated with breaking news from Cristina tassorelli. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Atogepant superior to rimegepant in reducing monthly migraine days at 12 weeks

Atogepant superior to rimegepant in reducing monthly migraine days at 12 weeks
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

Shenaz Bagha , Byrobert Herpen , Cristina Tassorelli , University Of Pavia , Robert Herpen ,

Atogepant well-tolerated, linked to significant migraine reduction

Atogepant well-tolerated, linked to significant migraine reduction
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

United States , Czech Republic , United Kingdom , Cristina Tassorelli , Byrobert Herpen , Shenaz Bagha , University Of Pavia , Robert Herpen ,

Teva reveals critical Ajovy data

Teva reveals critical Ajovy data
pharmatimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmatimes.com Daily Mail and Mail on Sunday newspapers.

Cristina Tassorelli , Pinar Kokturk , University Of Pavia , Teva Pharmaceutical Industries , Pharmaceutical Industries ,

Teva's (TEVA) interim analysis of PEARL real-world study on AJOVY reveals sustained long-term effectiveness

Teva's (TEVA) interim analysis of PEARL real-world study on AJOVY reveals sustained long-term effectiveness
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Cristina Tassorelli , Pinar Kokturk , University Of Pavia , Head Of Medical Affairs Europe At Teva , Department Of Brain , Behavioural Sciences , Teva Pharmaceutical Industries Ltd , European Academy Of Neurology , European Headache Federation , Teva Pharmaceutical Industries , European Academy , Professor Cristina Tassorelli , Professor Tassorelli , Medical Affairs Europe , Pan European Real World ,

Teva's 3rd interim analysis of PEARL real-world study on AJOVY® (fremanezumab) reveals sustained long-term effectiveness in reducing frequency, duration and severity of attacks in patients with chronic and episodic migraine

Data presented at the European Academy of Neurology Congress 2023 ....

Pinar Kokturk , Cristina Tassorelli , Behavioural Sciences , University Of Pavia , Teva Pharmaceutical Industries Ltd , European Headache Federation , Head Of Medical Affairs Europe At Teva , International Headache Society Clinical Trials Standing Committee , European Academy Of Neurology , Department Of Brain , Guidelines Of The International Headache Society , Teva Pharmaceutical Industries , European Academy , Professor Cristina Tassorelli , Professor Tassorelli , Medical Affairs Europe , Pan European Real World , Pharmaceutical Industries , Private Securities Litigation Reform Act , Quarterly Report , Annual Report , Real World , Persistence Along , Concomitant Migraine Medication Use , Fremanezumab Initiation , Migraine Severity ,